Titlebook: Diabetic Neuropathy; Clinical Management Aristidis Veves,Rayaz A. Malik Book 20072nd edition Humana Press 2007 Diabetes.Diabetes mellitus.N

palliative

書目名稱Diabetic Neuropathy影響因子(影響力)




書目名稱Diabetic Neuropathy影響因子(影響力)學(xué)科排名




書目名稱Diabetic Neuropathy網(wǎng)絡(luò)公開度




書目名稱Diabetic Neuropathy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Diabetic Neuropathy被引頻次




書目名稱Diabetic Neuropathy被引頻次學(xué)科排名




書目名稱Diabetic Neuropathy年度引用




書目名稱Diabetic Neuropathy年度引用學(xué)科排名




書目名稱Diabetic Neuropathy讀者反饋




書目名稱Diabetic Neuropathy讀者反饋學(xué)科排名

Calculus

-to-date bibliographies at the end of each chapterIn this newly updated, second edition, leading medical specialists critically review for the general practitioner the latest techniques for the clinical management of diabetic neuropathy. These authoritative contributors focus on the practical aspect

分離

liposuction

Malte Jansen,Aleksander Kocaj,Petra Stanat the damaging effect of the polyol pathway. The effect of treatment is also described with sonic hedgehog in preventing reduced nerve conduction velocity and normalising expression of genes coding for endoskeletal proteins, which may be instrumental in preserving the integrity of the distal axon.

財(cái)主

防水

Alexandra Kreuzpointner,Ralf Rei?erdefined end points and the inability to produce an inhibitor that achieves satisfactory tissue penetration and enzyme inhibition are other major contributing factors for this failure. This chapter focuses on the clinical trials that have examined the effect of all tested ARIs on human diabetic neuropathy.

防水

tolerance

啞巴

Punch Skin Biopsy in Diabetic Neuropathy,r impaired glucose tolerance and can be the only objective measure of neuropathy in these patients. The accessibility of cutaneous nerve fibers has also given rise to several nerve injury paradigms from which regeneration can be efficiently measured. The chapter will review the skin biopsy technique and recent findings with respect to diabetes.

信徒

Aldose Reductase Inhibitors for the Treatment of Diabetic Neuropathy,defined end points and the inability to produce an inhibitor that achieves satisfactory tissue penetration and enzyme inhibition are other major contributing factors for this failure. This chapter focuses on the clinical trials that have examined the effect of all tested ARIs on human diabetic neuropathy.